All Stories

  1. The Impact of ROS and NGF in the Gliomagenesis and their Emerging Implications in the Glioma Treatment
  2. The Impact of Alcohol Consumption and Oral Microbiota on Upper Aerodigestive Tract Carcinomas: A Pilot Study
  3. Blood Biomarkers from the Emergency Department Disclose Severe Omicron COVID-19-Associated Outcomes
  4. Molecular Pathology, Oxidative Stress, and Biomarkers in Obstructive Sleep Apnea
  5. The Impact of the COVID-19 Pandemic on the Prognosis of Laryngeal Adenoid Cystic Carcinoma: A Case Report and a Literature Review
  6. Diagnostic Predictors of Immunotherapy Response in Head and Neck Squamous Cell Carcinoma
  7. Investigating Biomarkers for COVID-19 Morbidity and Mortality
  8. COVID-19 Affects Serum Brain-Derived Neurotrophic Factor and Neurofilament Light Chain in Aged Men: Implications for Morbidity and Mortality
  9. Neurons, Nose, and Neurodegenerative Diseases: Olfactory Function and Cognitive Impairment
  10. The RNA-Binding Protein SMN as a Novel Player in Laryngeal Squamous Cell Carcinoma
  11. Neuroimmune Dysregulation in Prepubertal and Adolescent Individuals Affected by Klinefelter Syndrome
  12. The RNA-binding Protein SMN as a Novel Player in Laryngeal Squamous Cell Carcinoma
  13. Antioxidant Intervention to Improve Cognition in the Aging Brain: The Example of Hydroxytyrosol and Resveratrol
  14. Programmed Cell Death-Ligand 1 in Head and Neck Squamous Cell Carcinoma: Molecular Insights, Preclinical and Clinical Data, and Therapies
  15. Quality of T-Cell Response to SARS-CoV-2 mRNA Vaccine in ART-Treated PLWH
  16. Salivary Biomarkers in Oral Squamous Cell Carcinoma: A Proteomic Overview
  17. NGF and the Male Reproductive System: Potential Clinical Applications in Infertility
  18. The Impact of Oxidative Stress on Pediatrics Syndromes
  19. Prokineticin 2/PROK2 and Male Infertility
  20. Sudden Sensorineural Hearing Loss after Third Dose Booster of COVID-19 Vaccine Administration
  21. MicroRNA-Mediated Silencing Pathways in the Nervous System and Neurological Diseases
  22. Serum NGF and BDNF in Long-COVID-19 Adolescents: A Pilot Study
  23. Silencing of Ago-2 Interacting Protein SERBP1 Relieves KCC2 Repression by miR-92 in Neurons
  24. Exploring Mitochondrial Localization of SARS-CoV-2 RNA by Padlock Assay: A Pilot Study in Human Placenta
  25. Early Routine Biomarkers of SARS-CoV-2 Morbidity and Mortality: Outcomes from an Emergency Section
  26. Alcohol and Head and Neck Cancer: Updates on the Role of Oxidative Stress, Genetic, Epigenetics, Oral Microbiota, Antioxidants, and Alkylating Agents
  27. Exploring Mitochondrial Localization of SARS-CoV-2 RNA by Padlock Assay. A Pilot Study in Human Placenta
  28. Mediterranean Diet, Brain and Muscle: Olive Polyphenols and Resveratrol Protection in Neurodegenerative and Neuromuscular Disorders
  29. Fine-Tuning of mTOR mRNA and Nucleolin Complexes by SMN
  30. Alzheimer’s disease: new concepts on the role of autoimmunity and of NLRP3 inflammasome in the pathogenesis of the disease
  31. Cognitive Decline and Modulation of Alzheimer’s Disease-Related Genes After Inhibition of MicroRNA-101 in Mouse Hippocampal Neurons
  32. Involvement of the Chemokine Prokineticin-2 (PROK2) in Alzheimer’s Disease: From Animal Models to the Human Pathology
  33. Neuropeptides in Alzheimer’s Disease: An Update
  34. Circulating microRNA Profiles as Liquid Biopsies for the Characterization and Diagnosis of Fibromyalgia Syndrome
  35. MicroRNA Landscape in Alzheimer’s Disease
  36. Selective inhibition of miR-92 in hippocampal neurons alters contextual fear memory
  37. A lentiviral sponge for miR-101 regulates RanBP9 expression and amyloid precursor protein metabolism in hippocampal neurons
  38. Targeting microRNAs in neurons: Tools and perspectives
  39. Post-transcriptional regulation of amyloid precursor protein by microRNAs and RNA binding proteins
  40. MicroRNA-101 Regulates Amyloid Precursor Protein Expression in Hippocampal Neurons
  41. MicroRNA-92 modulates K(+) Cl(−) co-transporter KCC2 expression in cerebellar granule neurons
  42. RISC activity in hippocampus is essential for contextual memory
  43. Computational Challenges in miRNA Target Predictions: To Be or Not to Be a True Target?
  44. Searching for MIND: MicroRNAs in Neurodegenerative Diseases
  45. Thinking about RNA? MicroRNAs in the brain
  46. Che-1 enhances cyclin-dependent kinase 5 expression and interacts with the active kinase-complex
  47. Dicer expression and localization in post-mitotic neurons
  48. AMPA Receptors Are Modulated by Tachykinins in Rat Cerebellum Neurons
  49. Interaction of Tau with Fe65 links tau to APP
  50. Rb binding protein Che-1 interacts with Tau in cerebellar granule neurons
  51. Role of N-terminal tau domain integrity on the survival of cerebellar granule neurons
  52. A tachykinin-like factor increases glutamate toxicity in rat cerebellar granule cells
  53. Che-1 affects cell growth by interfering with the recruitment of HDAC1 by Rb
  54. Mild RIP –an alternative method for in vivo mutagenesis of the